What is the Reason for the Trend Shift from Dynamic Hip Screw to Cephalomedullary Nailing for the Treatment of Intertrochanteric Fractures? A Comprehensive Retrospective Study in a Single Tertiary Referral Hospital.

Background: The prevalence of intertrochanteric fractures is increasing with the aging population. Two surgical treatments, cephalomedullary nailing (CMN) and dynamic hip screw (DHS), have been widely utilized; however, recent trends indicate growing preference for CMN. While several studies have compared these 2 surgical methods, there has been limited comprehensive analysis with a substantial sample size from a single medical center aimed at minimizing bias.

Methods: This retrospective study was conducted at a single tertiary academic hospital, analyzing data from patients who underwent surgery for intertrochanteric fractures between January 2005 and December 2021. The study focused on comparing surgery-related parameters, postoperative local complications, medical complications, and mortality between patients treated with CMN and those treated with DHS.

Results: A total of 475 patients with a minimum follow-up of 3 months were enrolled. The mean (standard deviation) age of patients treated with CMN (77.0 ± 10.7 years) was older compared to those treated with DHS (73.0 ± 12.2 years; < 0.001). Overall, CMN demonstrated significantly better outcomes in reducing operation time (52.7 minutes vs. 88.2 minutes, < 0.001), estimated blood loss (EBL) (138.3 mL vs. 305.9 mL, < 0.001), intra- and postoperative transfusion packs (0.6 vs. 0.9, = 0.006), and length of hospital stay (12.0 days vs. 20.3 days, < 0.001), with similar findings in the unstable subgroups. However, in stable fracture cases, CMN showed superiority only in operation time and EBL (operation time: 49.6 minutes vs. 76.5 minutes, < 0.001; EBL: 103.8 mL vs. 254.8 mL, < 0.001). No differences were noted in postoperative outcomes including local complications, medical complications, and mortality.

Conclusions: Patients treated with CMN experienced no differences in postoperative outcomes including local and medical complications or mortality compared to DHS-treated patients. CMN reduced operation time, EBL, number of intraoperative and postoperative transfusion packs, and length of hospital stay, especially in patients with unstable intertrochanteric fractures. In conclusion, with comparable postoperative complications and mortality, CMN demonstrated superior perioperative efficiency, supporting its growing recommendation over DHS for the treatment of intertrochanteric fractures.